Combination of prophylactic subcutaneous mastectomy in a woman with a BRCA-1 gene mutation and subsequent pregnancy. Forensic medical aspect of the problem

Abstract

Risk-reducing mastectomy with BRCA-1, 2 gene mutation should be considered with the patient as part of a multidisciplinary team, which should include both an oncologist surgeon and a gynecologist oncologist, whose task is to explain the risks associated with ovarian preservation. With subcutaneous mastectomy with the preservation of the nipple-areolar complex, glandular tissue is preserved, which can cause lactation at the onset of pregnancy. These issues should be explained to patients, otherwise lawsuits against clinics and doctors who performed risk-reducing mastectomy are not excluded.